EUVIMEDEUVIMED entdecken
Fallbericht

High Cut-Off Renal Replacement Therapy for Removal of Myoglobin in Severe Rhabdomyolysis and Acute Kidney Injury: A Case Series

Nils Heyne, Martina Guthoff, Julia Krieger, Michael Haap, Hans-Ulrich Häring

Nephron Clinical Practice · 16.01.2013 · 121 (3-4) · c159-c164

DOI: 10.1159/000343564 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Nephron Clinical Practice, online erschienen am 16.01.2013. Verfasst von Nils Heyne und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Diabetology, Angiology, Nephrology and Clinical Chemistry, University of Tübingen, Tübingen, Germany. nils.heyne@med.…. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Aim: Rhabdomyolysis is associated with the release of myoglobin into the circulation, promoting acute kidney injury (AKI). In severe rhabdomyolysis, dialysis-dependent AKI doubles mortality. Standard blood purification techniques have limited efficacy in removing myoglobin. We describe high cut-off (HCO) renal replacement therapy (RRT) as a novel approach for extracorporeal elimination of myoglobin in rhabdomyolysis-associated AKI.

Methods

With an in vivo molecular cut-off at 45 kDa, HCO filters are effective in removing myoglobin (17.8 kDa). Clearances across standard and HCO filters using continuous or intermittent RRT are reviewed in a case series of 11 patients with severe rhabdomyolysis and dialysis-dependent AKI.

Results

Median myoglobin clearance across standard high-flux filters was 3.3 (interquartile range 2.3–3.9) ml/min for sustained low-efficiency daily dialysis (SLEDD) batch hemodialysis (HD) and 3.7 (2.9–6.7) ml/min for conventional HD. Respective clearances using HCO filters (membrane surface area: 1.1 m2) were 21.7 (20.3–26.1) ml/min (SLEDD) and 44.2 (41.3–47.0) ml/min (HD). Corrected for filter size, up to 20-fold higher clearances were obtained using HCO filters, resulting in profound and sustained reduction of plasma myoglobin concentration.

Conclusions

As a novel approach, HCO RRT allows for rapid and effective removal of myoglobin from the circulation. In light of the pathogenic role in AKI, reducing exposure of the kidney to myoglobin may improve renal recovery and patient outcome. Our data pave the way for prospective trials, addressing this issue.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Kidney InjuryAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedMyoglobinMyoglobinuriaRenal Replacement TherapyTreatment Outcome

Substanzen

Myoglobin

Autor:innen und Institutionen

  • Department of Endocrinology and Diabetology, Angiology, Nephrology and Clinical Chemistry, University of Tübingen, Tübingen, Germany. nils.heyne@med.uni-tuebingen.de

Zitieren

APA

Heyne, N., Guthoff, M., Krieger, J., Haap, M., & Häring, H. U. (2013). High Cut-Off Renal Replacement Therapy for Removal of Myoglobin in Severe Rhabdomyolysis and Acute Kidney Injury: A Case Series. Nephron Clinical Practice, 121(3-4), c159-c164. https://doi.org/10.1159/000343564

Vancouver

Heyne N, Guthoff M, Krieger J, Haap M, Häring HU. High Cut-Off Renal Replacement Therapy for Removal of Myoglobin in Severe Rhabdomyolysis and Acute Kidney Injury: A Case Series. Nephron Clinical Practice. 2013;121(3-4):c159-c164. doi:10.1159/000343564

BibTeX
@article{Heyne2013,
  author = {Heyne, Nils and Guthoff, Martina and Krieger, Julia and Haap, Michael and Häring, Hans-Ulrich},
  title = {High Cut-Off Renal Replacement Therapy for Removal of Myoglobin in Severe Rhabdomyolysis and Acute Kidney Injury: A Case Series},
  journal = {Nephron Clinical Practice},
  year = {2013},
  volume = {121},
  number = {3-4},
  pages = {c159--c164},
  doi = {10.1159/000343564}
}
Kostenlos starten →